Literature DB >> 34757822

Fucosylated Human Milk Oligosaccharide Foraging within the Species Bifidobacterium pseudocatenulatum Is Driven by Glycosyl Hydrolase Content and Specificity.

Guy Shani1, Jennifer L Hoeflinger1, Britta E Heiss1, Chad F Masarweh1, Jules A Larke2, Nick M Jensen1, Saumya Wickramasinghe1, Jasmine C Davis3, Elisha Goonatilleke3, Amr El-Hawiet4,5, Linh Nguyen5, John S Klassen5, Carolyn M Slupsky2,6, Carlito B Lebrilla3,6, David A Mills1,6,7.   

Abstract

Human milk enriches members of the genus Bifidobacterium in the infant gut. One species, Bifidobacterium pseudocatenulatum, is found in the gastrointestinal tracts of adults and breastfed infants. In this study, B. pseudocatenulatum strains were isolated and characterized to identify genetic adaptations to the breastfed infant gut. During growth on pooled human milk oligosaccharides (HMOs), we observed two distinct groups of B. pseudocatenulatum, isolates that readily consumed HMOs and those that did not, a difference driven by variable catabolism of fucosylated HMOs. A conserved gene cluster for fucosylated HMO utilization was identified in several sequenced B. pseudocatenulatum strains. One isolate, B. pseudocatenulatum MP80, which uniquely possessed GH95 and GH29 α-fucosidases, consumed the majority of fucosylated HMOs tested. Furthermore, B. pseudocatenulatum SC585, which possesses only a single GH95 α-fucosidase, lacked the ability to consume the complete repertoire of linkages within the fucosylated HMO pool. Analysis of the purified GH29 and GH95 fucosidase activities directly on HMOs revealed complementing enzyme specificities with the GH95 enzyme preferring 1-2 fucosyl linkages and the GH29 enzyme favoring 1-3 and 1-4 linkages. The HMO-binding specificities of the family 1 solute-binding protein component linked to the fucosylated HMO gene cluster in both SC585 and MP80 are similar, suggesting differential transport of fucosylated HMO is not a driving factor in each strain's distinct HMO consumption pattern. Taken together, these data indicate the presence or absence of specific α-fucosidases directs the strain-specific fucosylated HMO utilization pattern among bifidobacteria and likely influences competitive behavior for HMO foraging in situ. IMPORTANCE Often isolated from the human gut, microbes from the bacterial family Bifidobacteriaceae commonly possess genes enabling carbohydrate utilization. Isolates from breastfed infants often grow on and possess genes for the catabolism of human milk oligosaccharides (HMOs), glycans found in human breast milk. However, catabolism of structurally diverse HMOs differs between bifidobacterial strains. This study identifies key gene differences between Bifidobacterium pseudocatenulatum isolates that may impact whether a microbe successfully colonizes an infant gut. In this case, the presence of complementary α-fucosidases may provide an advantage to microbes seeking residence in the infant gut. Such knowledge furthers our understanding of how diet drives bacterial colonization of the infant gut.

Entities:  

Keywords:  Bifidobacterium; Bifidobacterium pseudocatenulatum; fucosidases; fucosylated HMO; glycan metabolism; milk oligosaccharides; strain specificity; substrate-binding protein; α-fucosidase

Mesh:

Substances:

Year:  2021        PMID: 34757822      PMCID: PMC8788745          DOI: 10.1128/AEM.01707-21

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   5.005


  58 in total

1.  Molecular cloning and characterization of Bifidobacterium bifidum 1,2-alpha-L-fucosidase (AfcA), a novel inverting glycosidase (glycoside hydrolase family 95).

Authors:  Takane Katayama; Akiko Sakuma; Takatoshi Kimura; Yutaka Makimura; Jun Hiratake; Kanzo Sakata; Takashi Yamanoi; Hidehiko Kumagai; Kenji Yamamoto
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

2.  Fast and sensitive protein alignment using DIAMOND.

Authors:  Benjamin Buchfink; Chao Xie; Daniel H Huson
Journal:  Nat Methods       Date:  2014-11-17       Impact factor: 28.547

3.  Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways.

Authors:  Angela Marcobal; Mariana Barboza; Erica D Sonnenburg; Nicholas Pudlo; Eric C Martens; Prerak Desai; Carlito B Lebrilla; Bart C Weimer; David A Mills; J Bruce German; Justin L Sonnenburg
Journal:  Cell Host Microbe       Date:  2011-10-27       Impact factor: 21.023

4.  Development of an annotated library of neutral human milk oligosaccharides.

Authors:  Shuai Wu; Nannan Tao; J Bruce German; Rudolf Grimm; Carlito B Lebrilla
Journal:  J Proteome Res       Date:  2010-08-06       Impact factor: 4.466

5.  Applications of a catch and release electrospray ionization mass spectrometry assay for carbohydrate library screening.

Authors:  Amr El-Hawiet; Glen K Shoemaker; Rambod Daneshfar; Elena N Kitova; John S Klassen
Journal:  Anal Chem       Date:  2011-12-06       Impact factor: 6.986

6.  A strategy for annotating the human milk glycome.

Authors:  Milady R Ninonuevo; Youmie Park; Hongfeng Yin; Jinhua Zhang; Robert E Ward; Brian H Clowers; J Bruce German; Samara L Freeman; Kevin Killeen; Rudolf Grimm; Carlito B Lebrilla
Journal:  J Agric Food Chem       Date:  2006-10-04       Impact factor: 5.279

7.  Evolutionary architecture of the infant-adapted group of Bifidobacterium species associated with the probiotic function.

Authors:  Min-Jung Kwak; Soon-Kyeong Kwon; Jae-Kyung Yoon; Ju Yeon Song; Jae-Gu Seo; Myung Jun Chung; Jihyun F Kim
Journal:  Syst Appl Microbiol       Date:  2016-07-29       Impact factor: 4.022

8.  Variation in consumption of human milk oligosaccharides by infant gut-associated strains of Bifidobacterium breve.

Authors:  Santiago Ruiz-Moyano; Sarah M Totten; Daniel A Garrido; Jennifer T Smilowitz; J Bruce German; Carlito B Lebrilla; David A Mills
Journal:  Appl Environ Microbiol       Date:  2013-07-26       Impact factor: 4.792

9.  Cross-talk between E. coli strains and a human colorectal adenocarcinoma-derived cell line.

Authors:  Xuan He; Darya O Mishchuk; Jigna Shah; Bart C Weimer; Carolyn M Slupsky
Journal:  Sci Rep       Date:  2013-12-04       Impact factor: 4.379

10.  Akkermansia muciniphila uses human milk oligosaccharides to thrive in the early life conditions in vitro.

Authors:  Ioannis Kostopoulos; Janneke Elzinga; Noora Ottman; Jay T Klievink; Bernadet Blijenberg; Steven Aalvink; Sjef Boeren; Marko Mank; Jan Knol; Willem M de Vos; Clara Belzer
Journal:  Sci Rep       Date:  2020-08-31       Impact factor: 4.379

View more
  3 in total

1.  2'-Fucosyllactose Increases the Abundance of Blautia in the Presence of Extracellular Fucosidase-Possessing Bacteria.

Authors:  Ayako Horigome; Nanami Hashikura; Keisuke Yoshida; Jin-Zhong Xiao; Toshitaka Odamaki
Journal:  Front Microbiol       Date:  2022-06-02       Impact factor: 6.064

2.  Comparative genomic analysis revealed genetic divergence between Bifidobacterium catenulatum subspecies present in infant versus adult guts.

Authors:  Jiaqi Liu; Weicheng Li; Caiqing Yao; Jie Yu; Heping Zhang
Journal:  BMC Microbiol       Date:  2022-06-16       Impact factor: 4.465

3.  Effects of addition of 2-fucosyllactose to infant formula on growth and specific pathways of utilization by Bifidobacterium in healthy term infants.

Authors:  John C Wallingford; Pernille Neve Myers; Cynthia M Barber
Journal:  Front Nutr       Date:  2022-09-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.